Skip to content
grad
Clinical Trials Portal

Clinical Trials Portal

Bon Secours Richmond Health System

  • Home
  • FAQs
Posted on April 23, 2019April 23, 2019 by Melissa Eckert

NRG Oncology NRG-BR004

A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First Line HER2-Positive Metastatic Breast Cancer

Read more about this trial →

← Back to available clinical trials

Post navigation

Previous PostPrevious SWOG LUNG-MAP
Next PostNext Merck MK3475-756

scope

What We’ve Been Up to Lately

Our research team was recently awarded with the Gold Certificate of Excellence by the NCI Community Oncology Research Program. This award is given to research teams who are able to enroll a specified number of patients onto NCI sponsored clinical trials within a certain time period. Our team is one of 43 total to have been given this award so far this year. We would not have been able to earn this award without the help of our wonderful patients and is a testament to them!

APPOINTMENTS AVAILABLE

To inquire about participation in a clinical trial, please contact us by phone at (804) 893-8717 or by email at rvaoncologyresearch@bshsi.org

See our FAQs

logo

logo logo

Bon Secours International | Sisters of Bon Secours USA | Bon Secours Health System
This page is managed by the Bon Secours Richmond Health System in Richmond, VA.
© 2017 Bon Secours Health System, Inc.

  • Yelp
  • Facebook
  • Twitter
  • Instagram
  • Email
Proudly powered by WordPress